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Abstract
Introduction. Rotavirus entry into cells seems to be mediated by sequential interactions between viral structural proteins 
and some cell surface molecules. However, the mechanisms by which rotavirus infects target cell are still not well unders-
tood. There is some evidence showing that rotavirus structural proteins VP5* and VP8* interact with some cell surface 
molecules. The availability of recombinant rotavirus structural proteins in sufficient quantity has become very important for 
the identification of the specific virus-cell receptor interactions during the early events of the infectious process. 
Objective. The aim of the present work is to perform an analysis of the interactions between recombinant rotavirus structu-
ral proteins VP5*, VP8* and VP6, and cellular proteins Hsc70 and PDI using their purified recombinant versions. 
Materials and methods. Rotavirus recombinant VP5* and VP8*, and cellular recombinant proteins Hsc70 and PDI were 
expressed in E. coli BL21(DE3) while VP6 was expressed in recombinant vaccinia virus-transfected MA104 cells. The inte-
raction between rotavirus and cellular proteins was studied using ELISA, co-immunoprecipitation and SDS-PAGE/Western 
blotting analysis. 
Results. The optimal conditions for expression of recombinant proteins were determined and antibodies were raised aga-
inst them. The findings suggested that viral proteins rVP5* and rVP6 interact with Hsc70 and PDI in vitro. These viral recom-
binant proteins were also found to interact with raft-associated Hsc70 in a cell culture system. The treatment of cells with 
either rVP6 or DLPs produced significantly inhibition of rotavirus infection. 
Conclusion. The results allow us to conclude that rVP5* and rVP6 interact with Hsc70 and PDI during the rotavirus infec-
tion process.
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Resumen
Introducción. La entrada de rotavirus a las células parece estar mediado por interacciones secuenciales entre las proteínas 
estructurales virales y algunas moléculas de la superficie celular. Sin embargo, los mecanismos por los cuales el rotavirus 
infecta la célula diana aún no se comprenden bien. Existe alguna evidencia que muestra que las proteínas estructurales de 
rotavirus VP5* y VP8* interactúan con algunas moléculas de la superficie celular. La disponibilidad de las proteínas estruc-
turales de rotavirus recombinantes en cantidad suficiente se ha convertido en un aspecto importante para la identificación 
de las interacciones específicas de los receptores virus-célula durante los eventos tempranos del proceso infeccioso. 
Objetivo. El propósito del presente trabajo es realizar un análisis de las interacciones entre las proteínas estructurales de 
rotavirus recombinante VP5*, VP8* y VP6, y las proteínas celulares Hsc70 y PDI utilizando sus versiones recombinantes 
purificadas. 
Materiales y métodos. Las proteínas recombinantes de rotavirus VP5* y VP8* y las proteínas recombinantes celulares 
Hsc70 y PDI se expresaron en E. coli BL21 (DE3), mientras que VP6 se expresó en células MA104 con virus vaccinia 
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Introduction
Rotavirus infection has been recognized as the leading 
cause of severe dehydrating diarrhea in infants and 
young children worldwide (Parashar et al., 2006; Espo-
sito et al., 2011 ), being responsible for more than half 
a million annual deaths globally (Parashar et al., 2006). 
Rotaviruses are non-enveloped viruses containing an 
11-segmented double-stranded (ds) RNA genome en-
closed by a triple-layered protein capsid (Pesavento 
et al., 2006; Estes et al., 2007). The outermost protein 
layer is composed by VP4 and VP7 while the interme-
diate layer consists of VP6. The innermost layer is built 
from VP2 which encloses the dsRNA segmented ge-
nome, and VP1 and VP3. VP4 requires to be cleaved 
into two trypsin proteolytic products, VP5* and VP8*, 
for the virus becomes infectious (Estes et al., 1981; Be-
nureau et al., 2005).
Rotaviruses exhibit a remarkable tropism for polari-
zed mature enterocytes from the small intestinal vi-
llus epithelium (Ramig 2004). However, primary small 
intestinal epithelial cell (IEC) cultures have been little 
used for rotavirus infection purposes (Kaushik et al., 
2008; Coulson et al., 2002; Macartney et al., 2000); 
most studies about rotavirus infection mechanism 
have been conducted in cultured cell systems such 
as MA104 cells, a non-differentiated kidney epithelial 
cell line (Guerrero et al., 2000; Londrigan et al., 2000; 
Halasz et al., 2008). The polarized epithelial cell line 
Caco-2 derived from a human colon adenocarcinoma 
(Fogh et al., 1977) has been also used as a model for 
studying the mechanisms by which rotaviruses affect 
intestinal functions (Servin et al., 2003; De Marco et al., 
2009; Beau et al., 2007). It has been shown that rota-
virus can replicate in Caco-2 cells being then released 
without destroying them (Jourdan et al., 1997).
The mechanisms by which rotavirus infects target cell 
are still not well understood. Rotavirus entry seems to 
be mediated by sequential interactions between viral 
structural proteins and some cell surface molecules 
(Lopez et al., 2006). There is evidence showing that 
sialic acid (SA) interacts with VP8*, the smaller trypsin 
cleavage product of VP4, during the initial virus bin-
ding to cell surface (Isa et al., 2006; Haselhorst et al., 
2009). Integrin α2β1 has been also found to mediate 
binding to cells for some rotavirus strains through di-
rect interaction with VP5*, the larger trypsin proteo-
lytic product of VP4 (Méndez et al., 1993; Zárate et al., 
2000). Rotavirus interaction with other integrins such 
as αxβ2 and αvβ3 through VP7 has been demonstra-
ted during post-binding events (Graham et al., 2003; 
Guerrero et al., 2000; Zárate et al., 2004). Cell surfa-
ce heat shock cognate protein 70 (Hsc70) has been 
shown to interact with VP5 and VP6 during rotavirus 
entry (Jolly et al., 2001; Guerrero et al., 2000; Zárate et 
al., 2004; Gualtero et al., 2007). VP5* implication in ro-
tavirus entry has been further extended by proposing 
that this viral protein could assume fusion-inducing 
conformational changes similar to those characterized 
in fusion proteins from enveloped viruses, leading to 
lipid bilayer perforation (Dormitzer et al., 2004; Trask 
et al., 2010). Rotavirus interaction with cell surface 
protein disulfide isomerase (PDI) has been suggested 
based on the sensitivity of rotavirus infection to DTNB 
[5,5-dithio-bis-(2-nitrobenzoic acid)], bacitracin, and 
anti-PDI antibody treatment (Wolf et al., 2011). Howe-
ver, the identity of the rotavirus cell surface receptor 
and entry mechanisms continuous to be a controver-
sial issue (Trask et al., 2010; Wolf et al., 2011; Ruiz, 
2009; Arias, 2002). 
Although the presence of Hsc70 and PDI has been 
documented in MA104 cells and their implication in 
rotavirus infection has been suggested by different stra-
tegies including the use of synthetic peptides derived 
from rotavirus proteins (Jolly et al., 2001; Guerrero et 
al., 2002; Zárate et al., 2003; Calderon et al., 2012) and 
antibodies against these cellular proteins (Calderon et 
al., 2012), a study of rotavirus-cell interaction using the 
entire rotavirus structural proteins will further provide 
important insights into how rotavirus enters into the 
host cell. The aim of the present work is to perform 
an analysis of the interactions between recombinant 
rotavirus structural proteins VP5*, VP8* and VP6, and 
cellular proteins Hsc70 and PDI in the context of rota-
virus entry. Interactions between viral proteins and ce-
llular proteins were followed by ELISA and SDS-PAGE/
Western blotting analysis of the immunoprecipitated 
complexes. Our findings confirm the usefulness of re-
recombinante transfectada. La interacción entre el rotavirus y las proteínas celulares se estudió mediante ELISA, co-inmu-
noprecipitación y SDS-PAGE/ Western. 
Resultados. Las condiciones óptimas para la expresión de proteínas recombinantes se determinaron y se generaron anti-
cuerpos contra ellas. Los resultados sugirieron que las proteínas virales rVP5* y rVP6 interactúan con Hsc70 y PDI in vitro. 
También se encontró que éstas proteínas virales recombinantes interactúan con Hsc70 en las balsas lipídicas (“Rafts”) en un 
cultivo celular. El tratamiento de las células, ya sea con DLP o rVP6 produjo significativamente la inhibición de la infección 
por rotavirus. 
Conclusión. Los resultados permiten concluir que rVP5 * y rVP6 interactúan con Hsc70 y PDI durante el proceso de la 
infección por rotavirus.
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combinant proteins in the identification of protein inte-
ractions during virus entry into the host cell. We show 
that addition of recombinant VP6 to MA104 cells led 
to the inhibition of rotavirus infection, suggesting its 
participation in the virus entry process. The results also 
extend the knowledge about rotavirus VP5* and VP6 
interaction with the cellular proteins Hsc70 and PDI 
which have been found to be implicated in virus entry 
into the host cell.  
Materials and methods
Expression of recombinant VP5*, VP8*,  
Hsc70 and PDI
Recombinant VP5* and VP8* fused with glutathione-
transferase (GST) were expressed in E. coli BL21(DE3) 
that had been transfected with pGEX-4T-VP5* and 
pGEX-4T-VP8* (Pharmacia, Stockholm, Sweden), 
respectively. Plasmids were kindly donated by Dr. C. 
F. Arias (Instituto de Biotecnología, Universidad Nacio-
nal Autónoma de México – UNAM). VP5* and VP8* 
are encoded by RRV (G3 P5B [3]) VP4 sequences 
spanning nucleotides 1 to 750, and 749 to 2347, res-
pectively (Zárate et al., 2000; Isa et al., 1997). Condi-
tions of transfection, expression and purification were 
previously described (Zhang et al., 2010). The purified 
VP5*-GST and VP8*-GST in Tris buffer (50 mM Tris-
HCl, pH 8.0, 10 mM CaCl2) were treated with throm-
bin (CleanCleave kit, Sigma, St. Louis, MO, USA) to 
cleave the GST tag from the fusion protein. 
Recombinant Hsc70 and PDI were expressed in E. 
coli BL21(DE3) which had been transfected with pET-
28a(+)-Hsc70 or pET-28a(+)-PDI expression vector 
(kindly donated by Dr. C. F. Arias, Instituto de Biotec-
nologia, UNAM, Cuernavaca, Mexico). A cDNA for 
human Hsc70 in plasmid pETHSC (GenBank acces-
sion No. M11717) (kindly provided by R. T. Morimo-
to, Northwestern University) containing the complete 
sequence of Hsc70 protein was subcloned into the 
pET28 expression vector (Novagene) to generate a fu-
sion protein with a six-histidine tail at its COOH-termi-
nus (Vargas et al., 2006). The rat liver PDI cDNA, taken 
as a TthIII-SalI fragment from pMAL5.1, and kindly do-
nated by Dr. R.T. Raines (Department of Chemistry, 
University of Wisconsin-Madison) was subcloned into 
the NdeI-SalI sites of pET28a (Novagen) (after blunting 
the NdeI site) to produce a fusion protein with a tail of 
six histidines at its NH2-terminus (Edman et al., 1985; 
Laboissiere et al., 1995).
BL21(DE3) competent E. coli cells were prepared as 
previously described  (Chung et al., 1989; Moreno et 
al., 2013)  with some modifications. An E. coli colony 
was resuspended in LB medium and grown overnight 
at 37 °C with orbital shaking (150 rpm). An aliquot (1 
ml) of the culture was inoculated in LB medium (100 
ml) to reach an OD 600 nm of 0.3 - 0.4 and then centri-
fuged (12000 g) for 10 min to collect the cells which 
were resuspended in 5 ml of freezing medium [10 % 
polyethylenglicol (PEG) 3350, 5 % dimethyl sulfoxide 
(DMSO), 100 mM NaCl, 10 mM MgCl2, 10 mM MgSO4, 
and 10 % glycerol in 60 % LB medium, pH 6.7 – 7.0] 
and aliquots were kept on ice for 5 min before being 
stored in liquid nitrogen. An aliquot was mixed with 
10 ng of pET-28a(+)-Hsc70 or pET-28a(+)-PDI expres-
sion vector dissolved in 100 ml of a solution containing 
100 mM KCl, 30 mM CaCl2 and 50 mM MgCl2. The 
suspension containing bacteria and plasmid DNA was 
gently agitated and incubated on ice for 20 min before 
heat shock treatment at 42 °C for 2 min. The transfec-
ted bacteria were seeded in LB-agar plates with 50 µg/
ml kanamicin and incubated for 14 h at 37 °C. 
A colony from bacteria transfected with pET-28a(+)-
Hsc70 was inoculated in 25 ml of LB medium contai-
ning 50 µg/ml kanamicin and incubated for 12 h at 
37 °C with orbital shaking (150 rpm). An aliquot (5 
ml) from this culture was inoculated into 500 ml of LB 
medium supplement with 50 µg/ml kanamicin and 2 
% glucose followed by incubation at 37 °C with orbital 
shaking (150 rpm) until the OD 600 nm profile indicated 
that the exponential growth phase was reached. Iso-
propyl thiogalactoside (IPTG) (0.5 to 2 mM final con-
centration) was added to the culture at this growth 
phase followed by further incubation for 2, 4, 6 or 8 h. 
In the case of bacteria transfected with pET-28a(+)-PDI, 
the procedures were as those described for Hsc70 ex-
pression vector, except that 2XYT medium was used. 
Recombinant protein expression was assessed by SDS-
PAGE/Western blotting analysis using non-transfec-
ted BL21(DE3) cells and transfected BL21(DE3) cells 
without IPTG treatment as a control. The total protein 
loaded into each gel well was spectrophotometrically 
quantified at 280 nm using a BSA standard curve. 
Solubilization and purification of recombinant 
Hsc70 and PDI
Solubilization of rHsc70 and rPDI from BL21(DE3) 
lysates was performed following the procedure repor-
ted (Frangioni et al.,1993) with some modifications. 
Bacteria were collected by centrifugation at 8000 g for 
10 min and washed twice with PBS. Cell pellets were 
resuspended in 50 ml PBS, treated with 100 µg/ml of 
lysozyme for 15 min at 4 °C with constant agitation. 
The suspension was made 5 mM in EDTA, 1% in so-
dium N-lauroylsarcosine and sonicated for 4 cycles 
of 15 sec at 20% amplitude before centrifugation at 
12000 g for 15 min at 4 °C. Triton X-100 at 1% was 
added and the presence of rHsc70 and rPDI was analy-
zed by SDS-PAGE and Western blotting. 
Recombinant proteins were purified using a 10 ml His 
Trap (BioRad) affinity column. The column was was-
hed with 5 volumes of 50 mM phosphate buffer con-
taining 300 mM NaCl and equilibrated with 5 volumes 
of the same buffer added with 10 mM imidazole. Cell 
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lysates were also added with 10 mM imidazole befo-
re applying on the column. Following washing with 
phosphate buffer containing 10 mM imidazole until no 
protein was detected with Bradford’s method, recom-
binant proteins were eluted from the column using 
increasing imidazole concentrations (0.25 – 1 M) in 
phosphate buffer. The column was finally washed with 
10 volumes of H2O and 5 volumes of 30% ethanol.       
Expression and purification of recombinant VP6
Recombinant VP6 was expressed in MA104 cells that 
had been infected with a recombinant vaccinia virus 
containing the rotavirus SA11 (G3 P5B (Esposito et al., 
2011) gene encoding structural VP6 (kindly donated 
by Dr. M. Franco, Instituto de Genetica, Universidad 
Javeriana). Recombinant VP6 containing 397 amino 
acids is encoded by a VP6 sequence spanning nucleo-
tides 1 to 1362 (Tang et al., 1997). Cells were cultured 
in Eagle Dulbecco’s modified medium (DMEM) supple-
mented with 2% fetal bovine serum (FBS) and 2 mM L-
glutamine at 37 °C in a 5% CO2 incubator. Cells at 80 
– 100% confluence were washed twice with PBS and 
infected with the recombinant vaccinia virus present in 
a MA104 cell lysate for 1 h at 37 °C. The remaining cell 
lysate containing the virus was removed and cells were 
incubated in Eagle minimal essential medium (MEM) 
for 24 h at 37 °C.
To identify the subcellular fraction in which VP6 is lo-
cated, the vaccinia virus-infected cells were frozen and 
thawed 3 times at – 70 °C, sonicated for 2 cycles of 
15 sec at 20% amplitude and centrifuged at 15000 g 
for 15 min at 4 °C. The soluble fraction (SF) was kept 
and the insoluble fraction (IF) washed twice with Tris 
buffer (20 mM Tris-HCl, pH 8.0, 150 mM KCl). The IF 
was treated with 1% Triton X-100 and 8 M urea before 
SDS-PAGE/Western blotting analysis. Solubilization of 
VP6 from the previously Tris buffer-washed IF was at-
tempted by resuspension in 1 ml RIPA buffer (10 mM 
Tris-HCl, pH 7.4, 0.1% SDS, 1% Triton X-100, 1% so-
dium deoxycholate and 150 mM NaCl 150) and incu-
bation for 1 h at 4 °C before centrifugation at 12000 
g for 10 min at 4 °C. The precipitated fraction was 
treated with 500 µl of Tris buffer containing 1% N-lau-
roylsarcosine, CHAPS, β-octylglucoside, Triton X-100, 
Tween 20, Nonidet P40 or sodium deoxycholate. The 
solubilized pellets were incubated overnight at 4 °C 
and then centrifuged at 12000 g for 10 min at 4 °C. 
The remaining pellet was further treated with 500 µl of 
8 M urea dissolved in buffer Tris (20 mM Tris-HCl, pH 
8.0, 150 KCl, 1% sodium lauroyl sarcosine). Proteins in 
each fraction were separated by SDS-PAGE, analyzed 
by Western blotting and compared with samples from 
uninfected cells. 
Purification of rVP6 was also attempted by a sequen-
tial treatment of the IF from recombinant vaccinia 
virus-infected cell lysates. The IF was sequentially trea-
ted with RIPA buffer followed by treatment with 1% 
β-octylglucoside, 8 M urea, and 8 M urea plus 1% N-
lauroylsarcosine in Tris buffer. The sequential pellets 
were obtained by centrifugation at 12000 g for 10 
min at 4 °C. The different solubilized fractions were 
analyzed by SDS-PAGE/Western blotting using rabbit 
polyclonal antibodies against rotavirus particles. The 
solubilized fractions containing rVP6 were dialyzed 
against a decreasing gradient of urea in PBS, diluted 
10 times in PBS and finally concentrated using Amicon 
Ultra – 4 (cut-off 10 kD; Millipore, Billerica, MA, USA).  
Production of antibodies against rVP6  
and rHsc70
Purified rHsc70 or partially purified rVP6 were separa-
ted in preparative 12% SDS-PAGE. Proteins in a gel lane 
were transferred onto a PVDF membrane and rHsc70 
or rVP6 were identified by Western blotting using 
rabbit polyclonal antibodies against either of these 
proteins, HRP-conjugated secondary goat anti-rabbit 
antibodies and 3-amino-9-ethylcarbazole (AEC) subs-
trate. Gels were stained with Coomassie blue and the 
identified proteins bands were excised from gels and 
distained in methanol-acetic (50% - 12.5%) solution 
before being equilibrated in PBS. Gel pieces were crus-
hed in PBS and the slurry passed several times through 
an 18-, 21- and then 23-gauge needle. Three month-old 
New Zealand rabbits were subcutaneously inoculated 
in the back with 750 µg of either recombinant protein 
emulsified in complete Freund’s adjuvant. Each rabbit 
received 3 injections spaced at 20 days intervals. Rab-
bits were bled 10 days after the final immunization and 
sera were obtained and mixed (1:1; v/v) with glycerol 
before storing at – 20 °C.
The antibodies raised against recombinant proteins 
were characterized by ELISA, immunochemistry and 
SDS-PAGE/Western blotting. ELISA plates were coated 
with growing concentrations (2.5 - 20 µg/ml) of rVP6 
in PBS, blocked with 1% BSA and reacted with rabbit 
antibodies against rVP6 diluted (1: 1000) in PBS con-
taining 0.05% Tween 20 and 0.1% BSA. Detection was 
performed with HRP-conjugated goat anti-rabbit anti-
bodies and AEC in 50 mM Na-acetate buffer, pH 5.0, 
and 0.04% H2O2. Immunocytochemistry analysis was 
carried out by infecting MA104 cell monolayers in 96-
well culture plates with purified trypsin activated RRV 
triple layered particles (TLPs) (MOI of 0.05). Cells were 
incubated for 1 h at 37 °C, washed twice with MEM 
and further incubated in MEM for 12 h at 37 °C. Cells 
were fixed in ice-cold methanol for 40 min and treated 
with dilutions (1:250 - 1:2000) of rabbit anti-rVP6 anti-
bodies in PBS for 1 h at 37 °C. HRP-conjugated secon-
dary antibody and AEC substrate in 50 mM Na-acetate 
buffer, pH 5.0, and 0.04% H2O2 were used for deve-
loping the reaction. Western blotting analysis of rabbit 
antibodies to rVP6 and rHsc70 was conducted using 
as antigen both purified recombinant proteins and cell 
lysates containing the recombinant proteins. Purified 
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RRV TLPs (500 ng/well) were also used as antigen to 
test anti-rVP6 antibodies. Lysates (25 – 100 µg protein/
well) from non transfected cell were used as a control. 
Rabbit antibodies diluted (1:1000) in PBS containing 
0.05% Tween 20 and 0.1% skimmed milk were added 
to membranes. Detection limit for anti-rVP6 serum 
was determined using dilutions (1:250 – 1:1000) of 
this serum to detect 250 ng/well of purified rVP6. HRP 
activity present in the secondary antibody used was 
visualized as described above for the immunochemis-
try assay.  
Interaction between rotavirus structural 
proteins and cellular Hsc70 and PDI  
Rotavirus structural proteins rVP5*, rVP8* and rVP6 
were tested for their interaction with cellular rHsc70 
and rPDI. ELISA was performed by coating 96-well pla-
tes with 40 µg/ml of rHsc70 or rPDI in PBS at 4 °C 
overnight and blocking with 1% BSA in PBS at 37 °C 
for 2 h. After washing with PBS, increasing concentra-
tions (1 – 20 µg/ml) of either rotavirus recombinant 
protein in the same buffer were added and incubated 
at 37 °C for 2 h. Wells were washed with PBS before 
addition of rabbit polyclonal antibodies (1:1000) aga-
inst rotavirus proteins in blocking buffer and incuba-
tion at 37 °C for 2 h. Antibodies against rVP5* y rVP8* 
were produced in our animal facilities (Zhang et al., 
2010). Reaction was detected using HRP-conjugated 
goat anti-rabbit antibodies and ortho-phenylenediami-
ne dihydrochloride (OPD) in substrate buffer (25 mM 
citric acid, 50 mm Na2HPO4, pH 5.0, containing 0.03% 
H2O2). For negative controls, 1% BSA was used instead 
of antibodies or rotaviral and cellular proteins. Data 
were expressed as mean of two independent experi-
ments performed with duplicate samples. The plate 
readings were done at 492 nm and the ΔOD values 
were calculated by subtracting mean values of control 
samples containing 1% BSA instead of antibodies or 
rotaviral and cellular recombinant proteins.
Co-immunoprecipitation analysis for interactions bet-
ween rotavirus proteins and cellular proteins was con-
ducted by incubating equal volumes (100 µl) of 2.5 µg/
ml of rVP5*, rVP8* or rVP6 with 10 µg/ml of rHsc70 or 
rPDI in the presence of 0.1% BSA. Each mix of proteins 
was maintained at 4 °C overnight prior addition of rab-
bit policlonal antibodies (1:200) against rotavirus pro-
teins and incubation for 1 h at 37 °C. BSA (4%)-treated 
Affi-Gel protein A-agarose (10 µl) (Bio-Rad, Hercules, 
CA, USA) was added to each mix (200 µl) of antibo-
dy-treated proteins followed by incubation for 1 h at 
room temperature, according to the manufacturer’s 
instructions. After incubation at room temperature 
for 1 h, the resin was washed 3 times with PBS-Tween 
20 (0.05%) and collected by centrifugation at 2000 g 
for 10 min. Protein in the precipitated complex was 
analyzed by SDS-PAGE/Western blotting using primary 
anti-Hsc70 or anti-PDI goat polyclonal antibodies fo-
llowed by addition of HRP-conjugated rabbit anti-goat 
antibodies and AEC substrate. rHsc70 or rPDI were in-
cubated with antibodies against rVP5*, rVP8* or rVP6 
and then immunoprecipitated to be used as a control. 
Conversely, the mix of viral and cellular proteins was 
immunoprecipitated with goat polyclonal antibodies 
(1 µg/ml, Santa Cruz Biotechnology Inc., Santa Cruz, 
CA, USA) against either Hsc70 or PDI and the Western 
blotting analysis was performed using rabbit primary 
antibodies against rVP5*, rVP8* or rVP6. These rota-
virus proteins were incubated with antibodies against 
Hsc70 or PDI and then immunoprecipitated to be used 
as a control.     
Interaction of VP5*, VP6 or VP8*  
with raft-associated Hsc70
The interaction between rotavirus proteins and Hsc70 
in lipid microdomains (rafts) was determined by mixing 
a MA104 cell suspension (9.2 x 106) (600 µl) with 100 
µl of rVP5* (15 µg/ml), rVP8* (15 µg/ml) or rVP6 (1.5 
µg/ml) followed by incubation for 1 h at room tempe-
rature. The cell viability was assessed using the Tripan 
blue exclusion test after treatment with recombinant 
proteins. Cells that had not been treated with rotavirus 
proteins were used as a control. Cells were washed 
twice with PBS and incubated with 120 µl of lysis bu-
ffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM 
CaCl2, 1 mM DTT, 1 % Triton X-100, 1 mM PMSF) 
during 30 min at 4 °C. The lysate was mixed (1:1; v/v) 
with 80% sucrose in buffer TNC (25 mM Tris-HCl, pH 
7.5, 150 mM NaCl; 1 mM CaCl2) in a centrifuge tube. 
A discontinuous sucrose gradient (30 – 5%) in TNC 
was layered onto the lysate and then centrifuged (Sor-
vall TST 60.4 at 170000 g for 8 h at 4 °C. The gra-
dient was fractionated and fractions were mixed with 
β-cyclodextrin (10 mM final concentration) and octyl-
glucoside (0.8% final concentration) and incubated at 
37 °C for 1 h. The fractions were incubated with goat 
polyclonal antibodies against Hsc70 (Santa Cruz Biote-
chnology Inc., Santa Cruz, CA, USA) at 37 °C for 1 h 
before addition of 30 µl Affi-Gel protein A-agarose and 
incubation for 30 min at room temperature. Proteins in 
the immunoprecipitated fractions were analyzed using 
Western blotting and the separated proteins detected 
with rabbit polyclonal antibodies against rVP5*, rVP8* 
or rVP6.
Infectivity inhibition assay 
The effect of rVP5*, VP8* or rVP6 on rotavirus infec-
tivity was assessed by adding either protein (1.2 – 40 
µg/ml) to a MA104 cell monolayer in 96-well culture 
plates and incubating for 1 h at 37 °C. Following the 
treatment of cells with the recombinant proteins, cell 
viability was assed using the Tripan blue exclusion test. 
RRV TLPs (50 µl) containing 5 x 104 FFU/ml were ino-
culated into cells followed by incubation for 1 h at 37 
°C. Cell monolayers were washed with PBS and incu-
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bated in MEM for an additional 12 h at 37 °C. Infectivi-
ty was determined by fixing cells in ice-cold methanol 
for 40 min and incubating them with rabbit anti-RRV 
antibodies (1:1000) in PBS for 1 h at 37 °C. HRP-conju-
gated goat anti-rabbit secondary antibody (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA) was used at 
0.133 µg/ml and developed with AEC substrate. Infec-
tivity was expressed as mean percentage of infected 
cells.
Results 
Expression and purification of rHsc70,  
rPDI and rVP6
The optimal conditions for expression of pET28a-
Hsc70 in E. coli BL21(DE3) were determined. These 
conditions included bacterial concentration (OD at 
600 nm) before induction, induction time, and induc-
tor concentration. Induction assays were conducted in 
bacterial cultures showing OD 600 nm values that ranged 
from 0.1 to 0.7 which encompassed the exponential 
growth phase and the starting of the stationary growth 
phase. A typical bacterial growth curve is shown in 
Fig. 1A. Expression of the rHsc70 was followed by 
SDS-PAGE and Western blotting analysis using rabbit 
anti-Hsc70 antibodies and taking into account the ex-
pected molecular mass (65 kDa) for this protein. In the 
absence of IPTG, no expression for rHsc70 was found 
either in the soluble or in insoluble fraction (Fig. 1B, la-
nes 2, 3). Addition of IPTG (1 mM final concentration) 
at OD 600 nm 0.1 – 0.4 for 4 h resulted in induction of 
basal expression of rHsc70 which was detected as a 
Western blot band present in either the soluble or in-
soluble fractions (Fig. 1B, lanes 4 – 11). IPTG induction 
at OD 600 nm 0.5 – 0.7 for 4 h led to rHsc70 expression 
only in the insoluble fraction (Fig. 1B, lanes 13, 15, 17). 
The highest amount of rHsc70 expression was obtai-
ned when the bacterial culture at OD 600 nm 0.5 was 
induced with IPTG (1 mM) for 4 h. In this case, rHsc70 
represented 1.02% of the total insoluble protein loa-
ded in SDS-PAGE wells (Fig. 1B, lane 13).  
Recombinant Hsc70 was found in both the soluble and 
insoluble fractions when cultures were induced with 
IPTG at concentrations that ranged from 0.5 to 2 mM 
(Fig. 1C, lanes 4 – 9) when the culture was induced at 
OD 600 nm 0.5. However, a higher proportion of rHsc70 
was always observed in the lysate insoluble fraction 
from cultures irrespective of the IPTG concentration 
used (Fig. 1C, lanes 5, 7, 9). Cultures induced with 1 - 
2 mM IPTG showed the highest total accumulation of 
rHsc70 (1.15%) relative to the total protein content 
in both fractions (Fig. 1C, lane 6 and 7). Variations in 
the IPTG concentration produced slight changes in the 
rate of rHsc70 accumulation and its location. In order 
to increase the rHsc70 accumulation and its location 
in the soluble fraction, the induction time effect was 
assessed between 2 and 8 h by treating the culture at 
OD 600 nm 0.5 with 1 mM IPTG. The recombinant protein 
was identified in all lysate fractions from cells induced 
during the times indicated (Fig. 1D, lanes 4 -11), but 
a higher accumulation of rHcs70 continued to be ob-
served in the insoluble fraction. However, the highest 
rHsc70 accumulation (1.39%) was detected in the in-
soluble fraction relative to the total protein present in 
both lysate fractions when induction with 1 mM IPTG 
was initiated at OD 600 nm 0.5 and maintained during 4 
at 37 °C. The rHsc70 contained in the insoluble frac-
tion was solubilized by treatment with PBS containing 
N-lauroylsarcosine and DTT but without EDTA to avoid 
Ni2+ chelating which interferes with rHsc70 binding to 
the resin during its purification. Additional treatment 
with 1% Triton X-100 was performed for refolding the 
recombinant protein and reducing nonspecific interac-
tion between bacterial proteins and the resin used for 
rHsc70 purification.  
The rHsc70 was efficiently purified as demonstrated by 
the comparison of the electrophoretic profiles corres-
ponding to the proteins present in the total lysate and 
the eluted fractions from the resin (Fig. 1E, lanes 2, 3). 
The analysis of fractions eluted from the resin with an 
imidazole gradient is shown in figure 1E (lanes 6 – 12). 
Fractions analyzed in lanes 8, 9 and 10 show the pre-
sence of some non-specific protein bands located both 
in the high and low molecular weight region. Western 
blotting analysis using rabbit polyclonal antibodies 
(1:1000) against Hsc70 showed that these antibodies 
specifically recognized the purified rHsc70 at amou-
nts as low as 62.5 ng/well (Fig. 1F, lane 6), whereas 
rHsc70 was detected in cell lysates only when samples 
contained at least 50 µg/well of total protein (Fig. 1G). 
PDI expression was efficiently induced with 0.5 mM 
IPTG during 4 h at 37 °C. The SDS-PAGE/Western blot-
ting analysis of lysates from the induced cells showed a 
55 kDa protein band which was identified as being PDI 
(Fig. 2A, lanes 4, 5). The PDI purification was carried out 
by treating cell lysates with PBS containing DTT and so-
dium N-lauroylsarcosine before passing them through 
a Ni2+ column. The profile of the fractions eluted with 
the imidazole gradient (0.25 – 1 M) is shown in Fig. 
2B. The highest amount of PDI eluted with 250 mM 
imidazole although some non-specific protein bands 
showing higher and lower molecular weight than PDI 
were observed (Fig. 2B, lanes 4, 5). Lower amounts of 
PDI were obtained at higher imidazole concentrations 
(Fig. 2B, lanes 6 - 11).   
Recombinant VP6 was expressed in MA104 cells after 
the infection with a recombinant vaccinia virus vector. 
The Western blotting analysis indicated that a protein 
band of 39 KDa corresponding to rVP6 was identified 
predominantly in the IF from the vaccinia virus-infected 
cell lysates (V-IL) (Fig. 3A, lane 5). Less rVP6 accumula-
tion was detected in the soluble fraction (Fig. 3A, lane 
4). This protein band was absent from non-infected cell 
lysates (N-IL) (Fig. 3A, lanes 6 and 7). Solubilization of 
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Figure 1. The optimal conditions for expression of recombinant Hsc70 in E. coli BL21(DE3). (A) Growth curve of E. coli BL21(DE3) 
transfected with pET-28a(+)-Hsc70 was determined in 2XYT medium by turbidimetry measurements at 600 nm. (B) Expression 
of rHsc70 was analyzed in both soluble (SF) and insoluble (IF) fractions by SDS-PAGE/Western blotting using primary rabbit 
antibodies against Hsc70. Proteins were stained with Coomassie blue. The anti-Hsc70 reaction is shown in the lower panel blot. 
Protein expression was determined following IPTG (1 mM) induction at the cell density (OD 600 nm) values indicated at the top 
of the upper panel. Non-induced (NI) cells were used as a control. Molecular weight markers (MW) are indicated. (C) Expression 
of rHsc70 in SF and IF was analyzed by SDS-PAGE/Western blotting after induction with the different concentrations of IPTG 
indicated at the top of the upper panel. Detection was performed using a primary rabbit antibody against Hsc70 as shown in the 
lower panel blot. (D) Expression of rHsc70 was analyzed by SDS-PAGE/Western blotting of SF and IF following the times (h) of 
IPTG (1 mM) induction indicated at the top o the upper panel. Detection was performed using a primary rabbit antibody against 
Hsc70. Anti-Hsc70 reaction is shown in the lower panel blot. (E) Purification of rHsc70 was carried out using a HisTrap (BioRad) 
affinity column followed by elution with an imidazole gradient at the concentrations indicated. Fractions eluted (E) from the co-
lumn were analyzed by SDS-PAGE. Total lysate (CL) and non-retained (NR) fraction were used as a control. (F) Characterization 
of rabbit policlonal antibodies against recombinant Hsc70. Different amounts (ng/well) of purified rHsc70 were analyzed in SDS-
PAGE and then transferred to PVDF membranes. Purified rHsc70 was detected with primary rabbit polyclonal antibodies against 
Hsc70 (1:1000). BSA was used as a control. (G) Different amounts (µg/well) of protein from MA104 cell lysates were separated 
by SDS-PAGE and then transferred to a PVDF membrane. Hsc70 was detected with primary rabbit polyclonal antibodies (1:1000) 
against Hsc70. BSA was used as a control.
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rVP6 from the IF was attempted by treatment with RIPA 
buffer followed by the recovery of a secondary insolu-
ble fraction which was further treated with 1% sodium 
N-lauroylsarcosine, CHAPS, β-octylglucoside, Triton 
X-100, Tween 20, Nonidet P40 or sodium deoxycho-
late. The treatment of the remaining pellets from the-
se detergent treatments with 8 M urea in Tris buffer 
showed that, despite some contaminant proteins, all 
the urea-solubilized fractions were enriched in rVP6 
(Fig. 3B). In order to eliminate additional contaminant 
proteins, the standard procedure for rVP6 purification 
started with RIPA treatment to solubilize some conta-
minant proteins from the cell lysate insoluble fraction 
(IF) (Fig. 3C, lane 3), followed by treatment of the re-
sultant pellet with 1% β-octylglucoside (Fig. 3C, lane 
4). Then, the remaining pellet was treated with 8 M 
urea (Fig. 3C, lane 5) and finally with 8 M urea plus 
1% sodium N-lauroylsarcosine (Fig. 3C, lane 6). Urea 
treatment of the IF in the absence of other treatments 
(Fig. 3C, lane 2) showed that the previous detergent 
treatments of the IF contributed to decrease contami-
nant proteins. The solubilized VP6 was dialyzed aga-
inst PBS and concentrated by ultrafiltration (Amicon 
Ultra 4, Millipore). 
Characterización of antibodies against  
VP6 and Hsc70
Western blotting analysis of anti-VP6 antibodies 
showed that these antibodies recognized the corres-
ponding viral antigen in lysates from vaccinia virus-
infected cells expressing recombinant VP6 when gel 
wells were loaded with 25 - 100 µg of total protein (Fig. 
4A, lanes 3 – 5). Purified rVP6 (500 – 62.5 ng/well) 
was also recognized in this analysis (Fig. 4B, lanes 3 
– 6). However, a positive reaction corresponding to a 
lower molecular weight band was seen which could be 
explained in terms of a degradation product from rVP6 
Figure 2. Expression of recombinant PDI in E. coli BL21(DE3). (A) Expression of rPDI in E. coli cultures induced and non-induced 
(NI) with IPTG (1 mM) was analyzed in both soluble (SF) and insoluble (IF) fractions by SDS-PAGE/Western blotting. Proteins in 
the gel were stained with Coomassie blue (upper panel) and PDI was detected using primary rabbit antibodies against PDI (lower 
panel). (B) Purification of rPDI was carried out using a HisTrap (BioRad) affinity column followed by elution with an imidazole 
gradient at the concentrations indicated. Eluted fractions (E) were analyzed by SDS-PAGE/Western blotting using primary rabbit 
anti.PDI antibodies. Total lysate (CL) and non-retained (NR) fraction were used as a control.
Interacciones de las proteínas disulfuro isomerasa y de choque térmico Hsc70 con proteínas estructurales rotavirales 41
(Fig.4A and B, lanes 3 and 4). Partially purified rVP6 
(250 ng) was detected by the highest dilution (1:3000) 
of the antiserum against rVP6 (Fig. 4C, lanes 2 – 5). 
VP6 from purified TLPs (500 ng/well) was also detec-
ted by Western blotting using anti-VP6 antibodies at 
dilutions ranging from 1:250 to 1:1000 (Fig. 4D, lanes 
4 – 6). ELISA showed increasing absorbance values 
for samples containing rVP6 (2.5 – 20 µg/ml) (Fig. 4E). 
Anti-VP6 antibodies at a dilution of 1:2000 showed to 
be useful for detecting RRV TLP-infected MA104 cells 
that had been inoculated with a MOI of 0.8 since more 
than 50% of cells were found to be positive to the vi-
ral antigen as detected by the immunochemistry assay 
(Data not shown). 
In vitro interaction of VP5*, VP8* and VP6 with 
Hsc70 and PDI
To assess the interaction between rotaviral proteins 
(VP5*, VP8* or VP6) and cellular proteins (Hsc70 or 
Figure 3. Expression of recombinant VP6 in MA104 cells. (A) Cell monolayers were infected with a recombinant vaccinia virus 
containing a SA11 nucleotide sequence encoding VP6. Soluble (SF) or insoluble (IF) fractions of lysates from both vaccinia-
infected (V-IL) and RRV infected (RRV-IL) MA104 cells were analyzed by SDS-PAGE/Western blotting. The membrane shown in the 
lower panel was reacted with rabbit polyclonal antibodies against RRV particles. Purified RRV TLPs, total RRV-infected cell lysate 
(RRV CL) and total non-infected cell lysates (N-IL) were used as a control. Molecular weight markers (MW) are indicated. Insoluble 
fractions (IF) (lanes 5 and 7) were solubilized by treatment with 8 M urea before analysis. (B) Insoluble fractions (IF) from recom-
binant vaccinia virus-infected cell lysates were solubilized in RIPA buffer or in Tris buffer containing the indicated detergents at 1%. 
SLAS: Sodium N-Lauroylsarcosine; OG: Octyl β-D-glucopyranoside; TX100: Triton X-100; TW20: Tween 20; NP40: Nonidet P-40; 
DOC: Sodium deoxycholate. Molecular weight markers (MW) are indicated. The solubilized proteins were submitted to SDS-PAGE/
Western blotting analysis. Proteins in the gel were stained with Coomassie blue (upper panel) and rotavirus proteins detected 
using rabbit polyclonal antibodies against RRV particles (lower panel). (C) Insoluble fractions (IF) from recombinant vaccinia 
virus-infected cell lysates were sequentially treated with RIPA buffer, β-octylglucoside, and 8 M urea plus N-lauroylsarcosine. The 
different solubilized fractions were analyzed by SDS-PAGE and stained with Coomassie blue. The arrow indicates the purified VP6. 
Total SF and IF from cell lysates (CL) were used as a control. Molecular weight markers (MW). IF solubilized with 8 M urea (lane 
2): IF solubilized with RIPA at 4 °C for 4 h (lane 3); Remaining pellet from the previous treatment that was solubilized with OG at 
1% (lane 4); Remaining pellet from the previous treatment that was solubilized with 8 M urea (lane 5); Remaining pellet from the 
previous treatment that was solubilized with urea plus SLAS at 1% (lane 6). 
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PDI), ELISA plates were coated with either of the latter 
proteins (40 µg/ml) and reacted with either rotaviral 
proteins at the concentrations indicated. Absorbance 
values showed an increasing profile which was directly 
proportional to the growing rVP5* concentrations (1 
– 8 µg/ml) added to rHsc70 coated wells (Fig. 5A). A 
similar interaction profile was observed when rHsc70 
coated wells were reacted with increasing rVP6 con-
centrations (0.078 – 1.25 µg/ml) (Fig. 5B). These fin-
dings suggest that viral rVP5* and rVP6 interact with 
Hsc70 at least in the in vitro conditions used. When 
rPDI coated ELISA wells were reacted with increasing 
rVP5* concentrations (1.25 – 10 µg/ml), and also with 
different rVP6 concentrations (0.156 – 2.5 µg/ml), a 
positive linear correlation with the absorbance values 
was found (Fig. 5D and 5E). Although absorbance va-
lues were relatively low mainly for VP5* (less than 0.2), 
these results suggest that rVP5* and rVP6 are directly 
interacting with PDI in vitro. ELISA results for rVP8* in-
teractions with Hsc70 or PDI were negative (Fig. 5C 
and 5F).
An immunoprecipitation assay was conducted to con-
firm the interactions found by ELISA. rPDI or rHsc70 
(10 µg/ml) were separately incubated with either rVP6 
(2.5 µg/ml), rVP5* or rVP8* (10 µg/ml). Immunopreci-
pitation was performed using specific antibodies aga-
inst either cellular protein. Western blotting analysis 
of the immunoprecipitated proteins showed the pre-
sence of recombinant viral proteins rVP5* and rVP6 
which were detected with the respective polyclonal 
antibodies (Fig. 5G and 5H). The immunoprecipitation 
results were not conclusive for VP8* since its mole-
cular weight was shared with that of immunoglobulin 
heavy chains which were recognized by the secondary 
antibody used in this assay (Fig. 5I). 
Reciprocal immunoprecipitation of the viral and cellu-
lar protein mix was also conducted using antibodies 
Figure 4. Characterization of rabbit policlonal antibodies against recombinant VP6. (A) Different amounts (µg/well) of lysate 
protein from vaccinia virus infected-cells expressing recombinant VP6 were separated by SDS-PAGE and then transferred to a PVDF 
membrane. Non-infected cell lysates were used as a control (N-IL). rVP6 was detected with primary rabbit polyclonal antibodies 
against VP6 (1:1000). (B) Different amounts (ng/well) of purified rVP6 were analyzed in SDS-PAGE and then transferred to PVDF 
membranes. Purified rVP6 was detected with primary rabbit polyclonal antibodies against VP6 (1:1000). (C) rVP6 (250 ng/well) 
were analyzed in Western blotting. Membranes were probed with decreasing dilutions of rabbit polyclonal antibodies against VP6. 
(D) TLP proteins (500 ng) were separated in SDS-PAGE and then transferred to PVDF membranes. Proteins were detected with in-
creasing dilutions of rabbit polyclonal antibodies against VP6 or rabbit anti-RRV TLP antibodies used as a control. (E) ELISA plates 
were coated with increasing amounts (µg/ml) of rVP6 and were detected with primary rabbit polyclonal antibodies against VP6 
(1:1000) and HRP-conjugated goat anti-rabbit antibody. 
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specifically directed against viral proteins. As shown in 
Fig. 5J (lanes 3 and 5), Hsc70 co-immunoprecipitated 
with rVP5* and rVP6 but no with rVP8* (lanes 7). Hsc70 
was not bound to the immunoprecipitation resin in the 
absence of viral protein addition (Fig. 5J, lanes 2, 4 and 
6). These results confirm the interaction between viral 
proteins (VP5* and VP6) and cellular proteins Hsc70 
and PDI. In the absence of antibody addition, no viral 
proteins were bound to the resin used in the immuno-
precipitation assay (Data not shown). 
Interactions between cell surface Hsc70 and viral 
proteins rVP5*, rVP8* and rVP6 
To test interactions between viral proteins and Hsc70, 
MA104 cell monolayer were separately incubated with 
rVP5*, rVP8* (15µg/ml) or rVP6 (1.5 µg/ml). Cells were 
lysed with Triton X-100 at 4 °C and the lipid microdo-
mains (rafts) fractionated by centrifugation through a 
sucrose gradient. After treatment of gradient fractions 
with β-clyclodextrin and β-octylglucoside, fractions 
were immunoprecipitated with antibodies against 
Hsc70 and analyzed by SDS-PAGE/Western blotting. 
Viral proteins were detected with specific antibodies 
against them. Cellular proteins Hsc70 (Fig. 6A, upper 
panel), PDI (Fig. 6A, middle panel) and integrin β3 (Fig. 
6A, lower panel) were detected in lipid raft fractions 
from control cells that had not been treated with viral 
proteins. These cellular proteins have previously been 
found to be associated in rafts from MA104 cells and 
also involved in rotavirus infection (Calderon et al., 
2012). It was also found that viral proteins VP5* and 
Figure 5. Interaction between rotavirus structural proteins and Hsc70 and PDI. ELISA plates were coated with 40 µg/ml Hsc70 
(A, B, C) or PDI (D, E, F) and then reacted with rVP5* (A and D), rVP6 (B and E) or rVP8* (C and F). Plate wells without cellular 
proteins, viral proteins or primary antibodies were used as controls. BSA instead of cellular or viral proteins was also used as a 
control. Values were expressed as ΔOD 492 nm, calculated as the difference between mean OD values from experiments and those 
from negative controls (A, B, D and E). VP6 (2.5 µg/ml) or VP5* or VP8* (10 µg/ml) were separately incubated with Hsc70 or PDI 
(10 µg/ml) and then co-immunoprecipitated and analyzed by SDS-PAGE/Western blotting. Proteins were co-immunoprecipitated 
with anti-Hsc70 or anti-PDI antibodies and the co-immunoprecipitated protein (IP) identified with anti-rVP5* (G), anti-rVP6 (H) 
or anti-rVP8* antibodies (I). (J) Co-immunoprecipitation was performed with antibodies against the viral proteins and identifica-
tion of the co-immunoprecipitated protein was identified with antibodies against Hsc70. 
44 Rev. Colomb. Biotecnol. Vol. XVIII No. 1  Enero-Junio 2016  33-48
VP6 co-immunoprecipitated with cellular Hsc70. The-
se results show that rVP5* (Fig. 6B, upper panel) and 
rVP6 (Fig. 6B, middle panel) were located in lipid ra-
fts interacting directly or indirectly with Hsc70. Again, 
identification of rVP8* resulted difficult as its molecular 
weight was similar to that from antibody heavy chains 
which reacted with the secondary antibody used (Fig. 
6B, lower panel). Gradient fractions from cells that had 
not been treated with viral proteins, were not reactive 
with antibodies against VP5* or VP6 after immunopre-
cipitation with anti-Hsc70 antibodies (Fig. 6C). This re-
sult excludes any non-specific reaction of antibodies 
against viral proteins.
Inhibitory effect of VP5*, VP8* or VP6 on RRV 
infection of MA104 cells
Previous work showed that MA104 cell infection with 
RRV TLPs was inhibited by treatment of cells with DLPs 
(double layered particles) (Dormitzer 2004). This su-
ggested that VP6 located on the surface of DLPs is 
involved in rotavirus penetration to host cell. In order 
to confirm this hypothesis, MA104 cell were incuba-
ted with viral proteins rVP5*, rVP8* or rVP6 for 1 h 
at 37 °C and then infected with RRV TLPs. Immuno-
chemistry detection after 12 h infection showed that 
infection was decreased by more than 90% when cells 
were previously incubated with rVP6 (0.5 µg/ml) (Fig. 
Figure 6. Identification of Hsc70, integrin β3 and PDI in lipid microdomains (rafts) and the interaction between raft-associated 
Hsc70 and recombinant viral proteins rVP5*, rVP6 and rVP8*. MA104 cell monolayers were lysed at 4 °C and centrifuged at 
38000 g in a sucrose gradient (30 - 5 %) for 8 h at 4 °C. The sucrose gradient fractions containing rafts were analyzed by SDS-
PAGE/Western blotting. (A) Cellular proteins were identified using polyclonal antibodies against Hsc70 (upper panel), PDI (middle 
panel) or integrin β3 (lower panel). (B) MA104 cell monolayers were incubated with viral proteins rVP5* (15 µg/ml), rVP8* (15 µg/
ml) or rVP6 (1.5 µg/ml) and the raft-containing sucrose gradient fractions were treated with 10 mM β-cyclodextrin and 1% octyl-
glucoside before being immunoprecipitated with rabbit polyclonal antibodies against Hsc70. The co-immunoprecipitated protein 
(IP) was analyzed by SDS-PAGE/Western blotting and viral protein identified with HRP-conjugated goat anti-rabbit antibodies (2 
ng/µl) against rVP5*, rVP6 and rVP8*. (C) Cells without addition of viral proteins were used as a control. Cells were processed as 
indicated in (B), except that blots were reacted with a mix of antibodies against VP5*, VP8* and VP6. 
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7B). rVP5* or rVP8* treatment of cells was unable to 
interfere with virus infection even at much higher con-
centrations than those used for rVP6 (Fig. 7A and 7C). 
Increasing DLP concentrations led to inhibition of virus 
infection when cells were DLP-treated before TLP infec-
tion (Fig. 7D). Trypan blue exclusion assay showed that 
cell viability was not affected by DLP treatment. These 
results confirm the implication of VP6 in the rotavirus 
infection process in MA1|04 cells. 
Discussion
Protein expression in heterologous systems has been 
a widely used strategy for investigating the molecular 
mechanisms underlying protein interactions. Expres-
sion vectors have been very useful in allowing uptake 
of genetic foreign material followed by its transcription 
and translation in heterologous systems (Sorensen 
et al., 2005; Sahdev et al., 2008). However, proteins 
expressed in heterologous systems usually are accu-
mulated forming insoluble inclusion bodies and their 
solubilization requires detergent treatments and pro-
cedures aimed at their in vitro refolding (Sahdev et al., 
2008). Insolubilization of VP5* and VP8* in hetero-
logous environments has been shown to depend on 
the expression systems used (Frangioni et al., 1993; 
Tang et al., 1997). In the present study, the conditions 
for expression of recombinant Hsc70 and PDI were 
compared in terms of bacterial concentration at the 
time of induction, time of induction and inductor con-
centration. Therefore, the optimum conditions for ex-
pression of the cellular proteins Hsc70 and PDI were 
established in an E. coli system. Optimum conditions 
for vaccinia virus expressing recombinant VP6 in the 
MA104 cell system were also defined. The urea and 
detergents assayed for solubilization of recombinant 
proteins in combination with the 6-his-tagged expres-
sion of Hsc70 and PDI allowed their efficient purifica-
Figure 7. Effect of rVP5*, rVP8*, rVP6 and DLPs on RRV infection. MA104 cells were incubated with different concentrations 
of viral proteins rVP5* (A), rVP6 (B), rVP8* (C) or DLPs (D) for 1 h at 37 °C. After, the cell monolayers was inoculated with RRV 
(1 MOI) for 1 h at 37 °C and the incubation was maintained for 12 h at 37 °C. Immunocytochemistry analysis was carried out 
using polyclonal antibodies against RRV particles. Virus infectivity was determined as mean percentage of infected cells relative 
to the control untreated cells. Cell viability was determined with the Trypan blue exclusion test and the concentrations of viral 
proteins used were measured at 280 nm against a BSA calibration curve.  The mean percentage of infection for untreated cells was 
normalized to 100%. 
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tion after using His Trap affinity columns. On the other 
hand, the specificity of the rabbit antibodies raised aga-
inst recombinant Hsc70 and VP6 was demonstrated 
by Western blotting analysis.  
The mechanisms associated with the rotavirus entry 
into the host cell continue to be a very controversial 
subject. The high level of purity of the recombinant 
proteins obtained from the expression and purification 
procedures described in the present work allowed 
their use to gain further insight into rotavirus-cell in-
teraction mechanisms. It had been previously shown 
that RRV DLPs were able to interfere with rotavirus 
infection in MA104 cells (Gualtero et al., 2007). This 
finding suggested that VP6 might be involved in ro-
tavirus entry. The results shown here indicated that 
addition of rVP6 to MA104 cells resulted in more than 
90% inhibition of virus infection. This new result gives 
further support to the hypothesis that this most abun-
dant rotavirus structural protein could be implicated 
in rotavirus entry. Llama-derived single-chain antibody 
fragments directed to rotavirus VP6 have been found 
to possess broad neutralizing activity both in vitro and 
in vivo against rotavirus infection (Garaicoechea et al., 
2008). The inhibition of rotavirus infection by either 
DLPs or VP6 could be explained by their binding to 
cell surface Hsc70 since this protein was found to inte-
ract with free or DLP-associated VP6 in ELISA (Gualtero 
et al., 2007) or co-immunoprecipitation assay. Diffe-
rential binding strength of Hsc70 to TLPs and DLPs has 
been previously reported (Guerrero et al., 2002). This 
finding could be explained by the apparent existence 
of two exposed Hsc70 binding sites in TLPs which are 
represented by the VP5* domains 642-658 (Zárate 
et al., 2003)  and 531- 554 (Gualtero et al., 2007). In 
contrast, the DLP-associated VP6 seems to have less 
Hsc70 binding sites (Gualtero et al., 2007).  
Hsc70 has been shown to interact with VP5* and 
DLPs in previous inhibition and competition studies 
(Guerrero et al., 2000; Zárate et al., 2004; Gualtero 
et al., 2007), and cell surface PDI has been found to 
be needed for rotavirus infection as thiol/disulfide in-
hibitors and antibodies to PDI interfere with virus in-
fection (Calderon et al., 2012). In the present work, 
ELISA and co-immunoprecipitation analysis led to con-
cluded that Hsc70 or PDI certainly interact physically 
with VP5* and VP6. The inhibitory binding of VP6 to 
Hsc70 following incubation of VP6 with MA104 cells, 
as evidenced in the co-immunoprecipitation assay, su-
ggests that VP6 binds to Hsc70 during the infectious 
process which results in a competition for rotavirus 
binding to cell surface Hsc70. Similarly, these interac-
tions were also found in raft-associated Hsc70 or PDI, 
although whether these interactions are direct or are 
mediated by an intermediary protein remains to be 
established. We propose that rotavirus entry involves 
the cell surface PDI reducing activity which probably 
generates thiol groups in VP5* and/or VP6 that con-
tribute either to virion disassembly or priming of viral 
proteins to interact with other cell surface receptors. 
The endoplasmic reticulum (ER)-associated oxidant PDI 
has been reported to interact with VP7 to generate 
the disulfide bridges which are needed for the proper 
VP7 folding during its assembly in TLPs (Svensson et 
al., 1994; Maruri-Avidal et al., 2008). Despite VP8* and 
immunoglobulin heavy chains could not be resolved 
by Western blotting analysis, and interaction between 
VP8* and Hsc70 or PDI remains to be elucidated. The 
treatment of Ma104 cells with VP5* or VP8* did not 
affect rotavirus infection. This finding would suggest 
that the binding of these proteins to the cell surface 
is dependent of conformational changes that are only 
produced when these proteins are associated to viral 
particles and interact with cell surface molecules du-
ring the infectious process. VP5* and VP8* failed to 
compete with viral particles probably because they lac-
ked the conformational changes required to interact 
with cellular receptors. Our results give support to the 
hypothesis that conformational rearrangements in ro-
tavirus particle proteins occur during the entry process 
which are similar to those generated in the HIV gp120 
envelope glycoprotein conformation  (Markovic et al., 
2004) or in the non-enveloped reovirus  (Madren et al., 
2012) or poliovirus  (Brandenburg et al., 2007) structu-
ral proteins in order to expose critical proteins to cell 
receptors. 
Taken together, the results presented here confirm the 
usefulness of recombinant proteins in the identification 
of protein interactions during virus entry into the host 
cell. However the sequence in which rotavirus VP5* 
and VP6 interact with Hsc70, PDI or other cellular pro-
teins during entry remains to be determined in more 
detail.   
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